194 related articles for article (PubMed ID: 7762505)
1. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.
Tsutamoto T; Kinoshita M; Hisanaga T; Maeda Y; Maeda K; Wada A; Fukai D; Yoshida S
Am J Cardiol; 1995 Jun; 75(16):1162-5. PubMed ID: 7762505
[TBL] [Abstract][Full Text] [Related]
2. Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure.
Tsutamoto T; Kinoshita M; Nakae I; Maeda Y; Wada A; Yabe T; Horie H
Am Heart J; 1994 Apr; 127(4 Pt 1):866-73. PubMed ID: 8154425
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
Larsen AI; Gøransson L; Aarsland T; Tamby JF; Dickstein K
Am Heart J; 1997 Sep; 134(3):435-41. PubMed ID: 9327699
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans.
Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE
J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713
[TBL] [Abstract][Full Text] [Related]
5. Plasma arteriovenous cGMP difference as a useful indicator of nitrate tolerance in patients with heart failure.
Tsutamoto T; Kinoshita M; Ohbayashi Y; Wada A; Maeda Y; Adachi T
Circulation; 1994 Aug; 90(2):823-9. PubMed ID: 8044954
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Circulation; 1998 Mar; 97(9):886-91. PubMed ID: 9521337
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic action of nicorandil in chronic congestive heart failure.
Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
[TBL] [Abstract][Full Text] [Related]
8. Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim.
Noguchi K; Matsuzaki T; Ojiri Y; Koyama T; Nakasone J; Sakanashi M
Fundam Clin Pharmacol; 1998; 12(3):270-8. PubMed ID: 9646059
[TBL] [Abstract][Full Text] [Related]
9. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
10. Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Jpn Circ J; 1998 May; 62(5):353-8. PubMed ID: 9626903
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tolerance to intravenous nitroglycerin during nicorandil and intermittent nitroglycerin patch in healthy volunteers.
Tabone X; Funck-Brentano C; Billon N; Jaillon P
Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):672-9. PubMed ID: 7995010
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of oral nicorandil in congestive heart failure.
Tice FD; Binkley PF; Cody RJ; Moeschberger ML; Mohrland JS; Wolf DL; Leier CV
Am J Cardiol; 1990 Jun; 65(20):1361-7. PubMed ID: 2140489
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic tolerance and pharmacokinetics of nicorandil in experimental heart failure.
Bachert EL; Fung HL
J Cardiovasc Pharmacol; 1993 May; 21(5):781-5. PubMed ID: 7685449
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of nicorandil in congestive heart failure.
Galié N; Varani E; Maiello L; Boriani G; Boschi S; Binetti G; Magnani B
Am J Cardiol; 1990 Feb; 65(5):343-8. PubMed ID: 2137279
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.
Elkayam U; Roth A; Henriquez B; Weber L; Tonnemacher D; Rahimtoola SH
Am J Cardiol; 1985 Sep; 56(8):555-9. PubMed ID: 3929585
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic and clinical effects of an intravenous potassium channel opener--a review.
Kato K
Eur Heart J; 1993 Jul; 14 Suppl B():40-7. PubMed ID: 8370372
[TBL] [Abstract][Full Text] [Related]
17. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
JAMA; 2002 Mar; 287(12):1531-40. PubMed ID: 11911755
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
J Am Coll Cardiol; 1998 Nov; 32(5):1194-200. PubMed ID: 9809925
[TBL] [Abstract][Full Text] [Related]
19. Comparison of development of tolerance between nicorandil and nitroglycerin in anesthetized, open-chest dogs.
Kuromaru O; Sakai K
Jpn J Pharmacol; 1986 Oct; 42(2):199-208. PubMed ID: 2948042
[TBL] [Abstract][Full Text] [Related]
20. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
Greenberg SS; Cantor E; Ho E; Walega M
J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
